Cocrystal Pharma, Inc. (COCP) financial statements (2021 and earlier)

Company profile

Business Address 19805 N. CREEK PARKWAY
BOTHELL, WA 98011
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7314941
Cash and cash equivalents7314941
Restricted cash and investments00     
Receivables1 00(2)(2) 
Disposal group, including discontinued operation      6
Other undisclosed current assets001235 
Total current assets:83251066
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment000000 
Intangible assets, net (including goodwill)196565656565
Goodwill196565656565 
Deposits noncurrent assets0      
Deferred costs  111  
Other undisclosed noncurrent assets 05353148187 
Total noncurrent assets:2066119119214253 
TOTAL ASSETS:29691211252242596
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2111310
Accounts payable21   0 
Accrued liabilities00 130 
Employee-related liabilities00     
Other undisclosed accounts payable and accrued liabilities  1   0
Debt00     
Deferred rent credit 0
Derivative instruments and hedges, liabilities0011  8
Disposal group, including discontinued operation      1
Other undisclosed current liabilities    483
Total current liabilities:22127912
Noncurrent Liabilities
Long-term debt and lease obligation101    
Long-term debt, excluding current maturities  1    
Finance lease, liability0
Capital lease obligations0     
Operating lease, liability1
Liabilities, other than long-term debt  142050653
Deferred revenue and credits0    
Deferred tax liabilities, net 14205065 
Disposal group, including discontinued operation, liabilities      3
Other undisclosed noncurrent liabilities   000 
Total noncurrent liabilities:10152150653
Total liabilities:321623577415
Stockholders' equity
Stockholders' equity attributable to parent, including:26671051021687(6)
Common stock0001100
Additional paid in capital2612542432392291928
Accumulated other comprehensive income     0 
Accumulated deficit(235)(187)(138)(137)(63)(12)(34)
Other undisclosed stockholders' equity attributable to parent     0 
Other undisclosed stockholders' equity     178 
Total stockholders' equity:2667105102168185(6)
Other undisclosed liabilities and equity      (3)
TOTAL LIABILITIES AND EQUITY:29691211252242596

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net  00 
Net investment income  (0)0   
Financial services revenue   0 
Gross profit:7  000 
Operating expenses(55)(63)(8)(106)(54)(6)(3)
Other operating expense, net
(Other Expenses)
     (0) 
Other undisclosed operating income (loss)  0(0) (0) 
Operating loss:(48)(63)(8)(106)(54)(6)(3)
Nonoperating income (expense)0012(11)11 
Investment income, nonoperating     6 
Other nonoperating income (expense)   2(11)6 
Interest and debt expense (0)    3
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 0   (6)(12)
Loss from continuing operations before income taxes:(48)(63)(7)(104)(65)(0)(12)
Income tax expense (benefit) 1472915(0) 
Loss from continuing operations:(48)(49)(1)(75)(50)(0)(12)
Loss from discontinued operations      (9)
Net loss:(48)(49)(1)(75)(50)(0)(20)
Other undisclosed net income attributable to parent     01
Net loss attributable to parent:(48)(49)(1)(75)(50)(0)(20)
Preferred stock dividends and other adjustments      (1)
Net loss available to common stockholders, diluted:(48)(49)(1)(75)(50)(0)(21)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(48)(49)(1)(75)(50)(0)(20)
Comprehensive loss:(48)(49)(1)(75)(50)(0)(20)
Other undisclosed comprehensive income, net of tax, attributable to parent     0 
Comprehensive income (loss), net of tax, attributable to parent:(48)(49)(1)(75)(50)0(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: